Lidocaine increases the energy required for ventricular defibrillation in dogs. Because sodium channel-blocking agents that are weak bases have pH-dependent electrophysiologic effects, we investigated the pH dependence of lidocaine (pKa, 7.9) on internal defibrillation energy requirements in 28 dogs with atrial spring and left ventricular patch electrodes. Results of defibrillation testing were used to derive 50% and 90% successful energy requirements (ED50 and ED90) using logistic regression and were compared with analysis of variance. Acidosis produced by hydrochloric acid infusion decreased the arterial pH from 7.40±0.05 (SD) to 7.18±0.03 (n=8, p<0.01), but no significant change in ED90 was observed (14±4 to 16+6 J).
and similar drugs is dependent on many factors, including drug concentration, rate (frequency) and time at any rate (use), transmembrane potential, and pH.7 Several investigators have successfully applied these in vitro findings to demonstrate block of sodium channels by antiarrhythmic drugs in vivo. [8] [9] [10] [11] In the present study, we have taken advantage of the pH-dependent electrophysiologic effects of lidocaine to test our hypothesis that the mechanism by which lidocaine affects defibrillation energy requirements is determined by its actions on the fast inward sodium channel current. We first investigated the effects of acidosis and alkalosis alone on internal defibrillation energy requirements in acute canine experiments. We then investigated the modulation of lidocaine's effect on defibrillation energy requirements by acidosis and alkalosis in further experiments.
Methods

Surgical Preparation
Acute studies were performed in adult mongrel dogs in accordance with the guiding principles of the American Physiologic Society. Under general anesthesia induced with intravenous sodium pentobarbital 30 mg/kg, dogs were intubated with a cuffed endotracheal tube and mechanically ventilated with a Harvard respirator pump with supplemental oxygen at 4 1/min. Indwelling femoral artery and vein catheters were placed for continuous arterial pressure recordings, arterial blood gas sampling, and intravenous infusions. A transvenous bipolar pacing and recording catheter was inserted into a jugular vein and advanced to the right ventricular apex. A defibrillating spring-coil electrode (Cardiac Pacemakers, St. Paul, Minnesota) was inserted into the other jugular vein and advanced to the level of the midright atrium. A left anterolateral thoracotomy incision was performed in the fifth intercostal space, the pericardium was opened, and a standard defibrillating patch electrode (Cardiac Pacemakers) was sutured directly to the left ventricular epicardium. The thoracotomy incision was then closed with chest drainage to Lidocaine-acidosis protocol. After baseline testing in six dogs, lidocaine loading of 7.5 mg/kg followed by a 150 ,ug/kg/min maintenance infusion was administered for testing in phase B. The lidocaine infusion used was lower in this protocol compared with the lidocaine-alkalosis experiments described below because it was anticipated from pilot studies that the combination of lidocaine and acidosis might otherwise result in defibrillation energy requirements exceeding the maximum output of our defibrillation testing instrument. In phase C, the lidocaine maintenance infusion was continued and acidosis produced as above for combined testing.
Lidocaine-alkalosis protocol. After baseline testing in six dogs, lidocaine loading of 7.5 mg/kg followed by a 225 ug/kg/min maintenance infusion was administered for testing in phase B. The lidocaine maintenance infusion was continued and alkalosis produced for combined testing in phase C.
Defibrillation Energy Determination
The methods used were identical to those previously described.2 In brief, ventricular fibrillation was induced by stimulation with a current-limited 120 Hz-rectified AC pulse across the bipolar pacing catheter. Internal ventricular defibrillation was accomplished by delivering a truncated exponential waveform of 60% tilt and variable duration via a customized instrument (ECD, Cardiac Pacemakers, St. Paul, Minnesota) across the spring-coil and patch electrodes. The ECD instrument allowed the selection of delivered energies from 1 to 40 J in 1-2 J increments.
Defibrillation test energies were delivered 10 seconds after the initiation of ventricular fibrillation. If the test energy was unsuccessful, higher internal energy of up to 40 J or external energy of up to 320 J via using a standard external defibrillator (Hewlett Packard, Palo Alto, California) and large skin electrodes (R2, Morton Grove, Illinois) were delivered. Only the results of the initial test energy were used for analysis. A minimum of 3 minutes between test energy determinations were required to ensure return of hemodynamic parameters to baseline.
Defibrillation energy requirements were determined by methods similar to those described by Davy et al. 12 After estimating the defibrillation "threshold" by testing four or five decremental energy levels, four energy levels were selected above and below the initially estimated energy level for testing five times each in balanced randomized order. This protocol was repeated for each experimental condition. Therefore, approximately 25 reversal in phase C.
fibrillation-defibrillation tests were performed for each of the three experimental conditions (a total of 75 fibrillation-defibrillation tests per dog).
Additional Measurements
Three surface electrograms, the bipolar right ventricular apical electrogram, the transcardiac electrogram between the spring-coil and patch electrodes, and intra-arterial pressure were continually monitored and recorded on photographic paper (Honeywell/E for M, White Plains, New York). Measurements of surface electrocardiographic intervals were averaged over five consecutive complexes. The mean interval between discrete electrogram deflections during ventricular fibrillation, which will be referred to as the ventricular fibrillation cycle length (VFCL), was measured from the right ventricular electrogram by averaging the activation intervals during the 2 seconds just before defibrillation. The right ventricular effective refractory period (RVERP) was determined for each experimental condition using ventricular pacing of cycle length 280 msec at twice diastolic threshold for eight beats followed by a single premature extrastimulus. The extrastimulus interval was decreased by 2 msec until reaching ventricular refractoriness with the RVERP defined as the longest coupling interval failing to result in capture.
Statistical Analysis
The defibrillation energy responses in each test phase were used to derive curves relating energy level to the percentage successful defibrillation attempts. Nonlinear regression was used to derive the best fit to the function: y=ex/(1+ex) where y is the proportion of successes at the energy level ED, x is (ln 9[ED-ED50])/[ED90-ED50], ED is the energy dose (J), ED50 is the 50% effective energy dose, and ED90 is the energy dose associated with 90% effective defibrillation. By parameterizing the logistic relationship in this way, estimates of ED50 and ED90 were obtained directly rather than by interpolation.
Analysis of the data was performed by two-way analysis of variance (ANOVA). If analysis of variance indicated a difference among means, Duncan's multiple-range test was used for pairwise comparisons. Lidocaine plasma concentrations between phases B and C were compared using the unpaired Student's t test. All results are expressed as mean+1 SD.
Results
Results from a total of 28 studies in four experimental protocols are summarized in Tables 1-3 . The mean dog weights were similar among protocols: 21.4+3.1 kg in the acidosis protocol, 20.0± 1.7 kg in the alkalosis protocol, 19.7+1.2 kg in the lidocaine/acidosis protocol, and 19.8+3.3 kg in the lidocaine/alkalosis protocol.
Defibrillation Energy Requirements
Examples of the relation between energy level and the percentage successful defibrillation attempts from individual experiments are illustrated in Figures 1-4 , and the overall effect of pH and lidocaine administration on the 90% effective defibrillation energy level is depicted in Figure 5 . Baseline defibrillation energy requirements were similar among the protocols with the mean ED50 ranging between 10 and 12 J and the mean ED90 between 13 and 15 J. In the acidosis protocol, hydrochloric acid infusion resulted in an insignificant increase in ED50 and ED90. In the alkalosis protocol, respiratory alkalosis resulted in a significant decrease in ED50 and ED90, which did not fully reverse after restoration to a normal pH. In the lidocaine/acidosis and lidocaine/ alkalosis protocols, lidocaine administration resulted in increases in ED50 and ED90. Infusion of hydrochloric acid during lidocaine administration resulted in further increases in ED50 and ED90. The mean ED90 increased by 69% (from 17±3 to 22±5 J) in the presence of moderate lidocaine plasma concentrations (mean, 3.4 ,ug/ml) and moderate acidosis (mean pH, 7.19). Production of respiratory alkalosis during lidocaine administration resulted in a complete reversal of the increases in ED50 and -'oor in mean Po2 values more than 200 mm Hg in all protocols and all phases. Po2 was unaffected by mechanical hyperventilation (or infusion of hydrochloric acid). No significant changes were detected in serum potassium levels in the acidosis, alkalosis, and lidocaine-alkalosis experiments. During lidocaine and acidosis experiments, there was a very small but significant increase in serum potassium from 3.9 to 4.2 meq/l.
Electrocardiographic and Electrophysiologic Intervals
As shown in Table 3 , the mean R-R intervals in sinus rhythm remained stable throughout the study period in all protocols. The QRS interval was unchanged during the acidosis and alkalosis protocols. During lidQcaine administration the QRS duration did not significantly prolong. The corrected QT interval shortened during acidosis and was unchanged during alkalosis. Lidocaine administration in phase B was associated with QT interval shortening in the lidocaine-acidosis protocol but did not reach statistical significance in the lidocainealkalosis protocol.
The mean ventricular fibrillation cycle length was unchanged in the alkalosis and acidosis experiments. With lidocaine administration, the mean ventricular fibrillation cycle length increased, particularly in the lidocaine-alkalosis experiments in which higher lidocaine plasma concentrations were obtained. Both acidosis and alkalosis were associated with increases in the right ventricular effective refractory period (RVERP) that did not reverse after restoration of pH. Lidocaine administration resulted in a trend toward increasing the RVERP, but statistical significance was reached only in phase C in combination with pH changes.
Discussion
In the present study, we have shown that defibrillation energy requirements are not significantly affected by acidosis produced by hydrochloric acid infusion and are decreased by alkalosis produced by respiratory hyperventilation. The increase in defibrillation energy requirements by lidocaine are enhanced in the presence of acidosis and reversed in the presence of alkalosis. Thus, in these experiments, lidocaine exhibited pH-dependent effects on defibrillation energy requirements in dogs consistent with its sodium channel-blocking properties.
The effects of acidosis and alkalosis alone on defibrillation energy requirements have not been reported. Other investigators have evaluated the effects of acidotic pH resulting from a combination of ischemia, hypoxia, and prolonged ventricular fibrillation, but those studies are not comparable. Although pH changes can alter serum potassium levels, small changes in serum potassium levels did not significantly alter defibrillation energy requirements in preliminary experiments in our laboratory. The effect on defibrillation energy is unlikely to be due to differences in oxygenation because the Po2 was unchanged, even during mechanical hyperventilation. The mean right ventricular effective refractory period was prolonged during both acidosis and alkalosis; this might suggest that myocardial refractoriness measured in the fashion adopted in this study is not an important factor in determining defibrillation energy requirements. The failure of pH reversal to completely restore defibrillation energy requirements to baseline values probably reflects slower reequilibration of intracellular pH compared with arterial pH. It is unlikely that this represents deterioration of the animal preparation in that the changes due to acidosis and alkalosis were in opposite directions. Moreover, in previous studies, the defibrillation energy requirements, electrocardiographic measurements, ventricular fibrillation cycle length, and RVERP were unchanged after similar testing over the same time period.2 In general, lidocaine administration resulted in findings similar to previous studies, increased defibrillation energy requirements (EDSO and ED90),2-6 QRS interval widening, QTc interval shortening, and prolongation of the ventricular fibrillation cycle length.2 Despite the differences in the two lidocaine infusion regimens, the mean percent increase in defibrillation energy requirements at normal pH were unexpectedly similar; in the lidocaine/acidosis protocols, the ED50 increased 44% and the ED90 increased 30%, while in the lidocainealkalosis protocol, the ED50 increased 50% and the ED90 increased 33%. We attribute this to interindividual variation in defibrillation energy requirements and drug responsiveness.
The effects of moderate alterations in arterial pH in the presence of lidocaine were substantial. Lowering the pH in the presence of midtherapeutic lidocaine plasma concentrations caused the defibrillation energy requirements to increase to an extent seen previously only at toxic lidocaine plasma concentrations. 2, 5 In contrast, raising the pH in the presence of high lidocaine plasma concentrations (mean, 7.7 ,gg/ml) resulted in a complete reversal of effects on ED50 and ED90 to baseline or even below baseline energy levels. Because the lowering of ED50 and ED90 with alkalotic pH in the presence of lidocaine exceeded that seen with alkalotic pH alone, we believe that lowering of defibrillation energy requirements by a combination of lidocaine and alkalosis cannot be attributed to the effects of alkalosis alone. Furthermore, the lidocaine plasma concentrations remained stable during phases B and C of both experimental protocols such that fluctuations in plasma lidocaine levels cannot explain our experimental findings.
Potential Mechanisms
Lidocaine is a weak base (pKa 7.913), present in both cationic and neutral form at physiologic pH. Small changes in pH can result in substantial changes in the ratio of charged to uncharged drug and can account for differences in drug effects. In vitro, lidocaine has been shown to exhibit pH dependence attributed to its sodium channel-blocking activity.7,14 Briefly, in the presence of acidosis, the effects of lidocaine are believed to be enhanced because the recovery rate from sodium channel block is slowed, while the development of block is not significantly reduced because of lengthening of action potential duration.15-17 Acidosis may also cause an increase in extracellular potassium that would cause transmembrane depolarization and enhance voltagedependent drug block. Davis et a18 studied usedependent and pH-dependent effects of lidocaine in the intact dog and demonstrated potentiation of HV prolongation by lidocaine during acidotic pH (mean pH, 7.18). On the other hand, alkalosis causes a lower charged-to-neutral drug ratio, which results in faster recovery from lidocaine block; in addition, alkalosis lowers external potassium, which hyperpolarizes the transmembrane potential and may reduce the effects of lidocaine.
These experiments were not designed to yield in vivo data to validate in vitro electrophysiologic findings; other such data is available.8-1 We have hypothesized that antiarrhythmic agents modulate defibrillation energy requirements by virtue of their electrophysiologic actions on ionic channels. Our hypothesis, therefore, predicts that the effects of lidocaine on defibrillation energy requirements can be modulated by factors that control sodium channel activity. The results in this study of defibrillation energy are consistent with the pH-dependent sodium channel action of lidocaine, but it is possible that other mechanisms are important.2
Potential Limitations
These studies were performed in anesthetized dogs with normal hearts; therefore, caution should be applied in extrapolating the results to humans. Lidocaine's effects were found to be dependent on the anesthetic agent in one study. 6 The acidosis and alkalosis were artificially created and may be different from that occurring in clinical settings. Finally, we cannot exclude the possibility that the effects we attribute to changes in pH are not actually due to some ancillary factor that we did not measure or did not control (e.g., potassium concentration).
Clinical Implications
If these studies have clinical relevance, the results may influence the treatment of ventricular fibrillation in patients receiving lidocaine and defibrillation with either an internal implantable device or an external electrical source. Patients receiving lidocaine who become acidotic may be difficult to defibrillate; reversing the acidosis should improve the energy requirements. If the patient could be made moderately alkalotic, the defibrillation energy requirements may be restored to baseline. Because these pH-dependent effects are complex and dependent on the specific drug, it would be premature to attempt to extrapolate these results to other antiarrhythmic drugs that block sodium channels.
